Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | CASP1 | P29466 | 1/20 | 0.53 |
| ▸ | STAT6 | P42226 | 1/20 | 0.53 |
| ▸ | CASP7 | P55210 | 1/20 | 0.53 |
| ▸ | HBB | P68871 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 5/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluorescin SCHEMBL31164674 | 1.00 | CYP2C9 (0.71) | CYP2C9ALDH1A1HSD17B10BRCA1CYP3A4 | |
| Fluorescin SCHEMBL29370997 | 1.00 | CYP2C9 (0.71) | CYP2C9ALDH1A1HSD17B10BRCA1CYP3A4 | |
| Fluorescin SCHEMBL31164673 | 1.00 | CYP2C9 (0.71) | CYP2C9ALDH1A1HSD17B10BRCA1CYP3A4 | |
| Fluorescin SCHEMBL31214151 | 1.00 | CYP2C9 (0.71) | CYP2C9ALDH1A1HSD17B10BRCA1CYP3A4 | |
| Fluorescin SCHEMBL1507667 | 0.98 | CYP2C9 (0.69) | CYP2C9ALDH1A1HSD17B10BRCA1CYP3A4 | |
| Fluorescin SCHEMBL1938032 | 0.98 | CYP2C9 (0.69) | CYP2C9ALDH1A1HSD17B10BRCA1CYP3A4 | |
| Fluorescin SCHEMBL5579981 | 0.94 | CYP2C9 (0.64) | CYP2C9ALDH1A1HSD17B10BRCA1CYP3A4 | |
| Fluorescin SCHEMBL4342272 | 0.94 | CYP2C9 (0.64) | CYP2C9ALDH1A1HSD17B10BRCA1CYP3A4 | |
| Fluorescin SCHEMBL7807189 | 0.94 | CYP2C9 (0.64) | CYP2C9ALDH1A1HSD17B10BRCA1CYP3A4 | |
| Fluorescin SCHEMBL6036317 | 0.93 | CYP2C9 (0.62) | CYP2C9ALDH1A1HSD17B10BRCA1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9990 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3715466-B1 | METHOD FOR IN VIVO EVALUATION OF BIOLUMINESCENCE | CALIPER LIFE SCIENCES INC (US) | 2025-05-07 | — | — | EP | claimed |
| WO-2025090061-A1 | ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION | JP LABORATORIES, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| US-20250035628-A1 | BIOASSAYS TO MEASURE THE SYNERGISTIC ANTIBODY-DEPENDENT ENHANCEMENT (ADE) EFFECT OF SARS-CoV-2 NEUTRALIZING ANTIBODIES | WuXi Biologics Ireland Limited (IE) | 2025-01-30 | — | — | US | claimed |
| WO-2024259294-A2 | PROTEOMIMETIC SCAFFOLDS AND USES THEREOF | NEW YORK UNIVERSITY (US) | 2024-12-19 | — | — | WO | claimed |
| WO-2024255853-A1 | CELL-BASED ASSAYS USING IMMOBILIZED RECOMBINANT PROTEINS TO MEASURE IMMUNE REGULATION OF THERAPEUTIC BIOLOGICS | WUXI BIOLOGICS (SHANGHAI) CO., LTD. (CN) | 2024-12-19 | — | — | WO | claimed |
| EP-4444750-A1 | BIOASSAYS TO MEASURE SYNERGISTIC ANTIBODY-DEPENDENT ENHANCEMENT (ADE) EFFECT OF SARS-COV-2 NEUTRALIZING ANTIBODIES | WuXi Biologics Ireland Limited (IE) | 2024-10-16 | — | — | EP | claimed |
| CN-117580498-A | System and method for identifying abnormal perfusion patterns | 灌注科技有限公司 | 2024-02-20 | — | — | CN | claimed |
| WO-2023103856-A1 | BIOASSAYS TO MEASURE SYNERGISTIC ANTIBODY-DEPENDENT ENHANCEMENT (ADE) EFFECT OF SARS-CoV-2 NEUTRALIZING ANTIBODIES | WUXI BIOLOGICS (SHANGHAI) CO., LTD. (CN) | 2023-06-15 | — | — | WO | claimed |
| US-20230151407-A1 | A METHOD FOR MULTIPLEXED DETECTION OF A PLURALITY OF TARGET BIOMOLECULES | APLEX BIO AB (SE) | 2023-05-18 | — | — | US | claimed |
| EP-4133273-A1 | A METHOD FOR MULTIPLEXED DETECTION OF A PLURALITY OF TARGET BIOMOLECULES | Aplex Bio AB (SE) | 2023-02-15 | — | — | EP | claimed |
| EP-0394277-A1 | SECOND GENERATION MONOCLONAL ANTIBODIES HAVING BINDING SPECIFICITY TO TAG-72 AND HUMAN CARCINOMAS AND METHODS FOR EMPLOYING THE SAME | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1990-10-31 | — | — | EP | claimed |
| EP-0383126-A2 | Photopolymerization diagnostic test composition and method for immunoassay and nucleic acid assay | OSTER, Gerald (US) | 1990-08-22 | — | — | EP | claimed |
| EP-0152267-B1 | STANDARD FOR ANALYSIS | AMERSHAM INTERNATIONAL plc (GB) | 1989-12-27 | — | — | EP | claimed |
| EP-0182179-B1 | INTEGRAL MULTILAYER ANALYTICAL ELEMENT FOR USE IN THE MEASUREMENT OF ALKALINE PHOSPHATASE ACITIVITY | FUJI PHOTO FILM CO., LTD. (JP) | 1989-10-18 | — | — | EP | claimed |
| WO-1989000692-A1 | SECOND GENERATION MONOCLONAL ANTIBODIES HAVING BINDING SPECIFICITY TO TAG-72 AND HUMAN CARCINOMAS AND METHODS FOR EMPLOYING THE SAME | THE UNITED STATES OF AMERICA, AS REPRESENTED BY TH (US) | 1989-01-26 | — | — | WO | claimed |
| EP-0131830-B1 | LABELLED NUCLEIC ACID PROBES AND ADDUCTS FOR THEIR PREPARATION | MOLECULAR DIAGNOSTICS, INC. (US) | 1986-12-10 | — | — | EP | claimed |
| EP-0101681-A4 | Antibody to a mediator activity composition and its use in a pharmaceutical composition. | UNIV ROCKEFELLER (US) | 1985-06-06 | — | — | EP | claimed |
| EP-0101681-A1 | Antibody to a mediator activity composition and its use in a pharmaceutical composition. | UNIV ROCKEFELLER (US) | 1984-03-07 | — | — | EP | claimed |
| WO-1983000930-A1 | LIPOPROTEIN LIPASE SUPPRESSION BY ENDOTOXIN-INDUCE MEDIATOR (SHOCK ASSAY) | UNIV ROCKEFELLER (US) | 1983-03-17 | — | — | WO | claimed |
| US-4346159-A | Photosensitive element for electrophotography | FUJI XEROX CO., LTD. (JP) | 1982-08-24 | — | — | US | claimed |